Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Gilgamesh Pharmaceuticals

Biotech & Life Sciences · New York City, United States · Founded 2019 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$100–500M
Latest valuation · Mar/2026
Unlock exact value
Revenue
$50–100M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

13 investors on Gilgamesh Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Y Combinator
Series A 7 investors entered at this stage
Palo Alto Investors
Gron Ventures
Satori Neuro
JLS Fund
Prime Movers Lab
Noetic Fund
Route 66 Ventures
Series B+ 5 investors entered at this stage
Ayuh Ventures
Negev Capital
Palo Santo Venture Fund
Satori Capital
Alumni Ventures

Global footprint

Where Gilgamesh Pharmaceuticals has talent and traffic

Web traffic by country
3.6K monthly visits
across markets
🇺🇸 United States94.4%
🇬🇧 United Kingdom5.6%
Top 2 markets shown

See Gilgamesh Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo